Relationship between serum insulin-like growth factor-1, IGF binding protein-3 levels and body height before and after gonadotropin-releasing hormone agonist therapy

PURPOSE: The gonadotropin-releasing hormone agonist (GnRHa) is widely used to treat patients with precocious puberty. However, its effect on growth is often difficult to predict because of the diverse nature of its causes and presentation. This study aims to show the impact of GnRHa treatment on ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Han Sol, Choi, Won Bok, Song, Joon Sup, Hwang, Il Tae, Yang, Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pediatric Endocrinology 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316410/
https://www.ncbi.nlm.nih.gov/pubmed/25654067
http://dx.doi.org/10.6065/apem.2014.19.4.208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316410/
https://www.ncbi.nlm.nih.gov/pubmed/25654067
http://dx.doi.org/10.6065/apem.2014.19.4.208

Ejemplares similares